85 related articles for article (PubMed ID: 26475812)
1. Long-term outcome in kidney recipients from donors treated with hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6.
Blasco V; Colavolpe JC; Antonini F; Zieleskiewicz L; Nafati C; Albanèse J; Leone M
Br J Anaesth; 2015 Nov; 115(5):798. PubMed ID: 26475812
[No Abstract] [Full Text] [Related]
2. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.
Blasco V; Leone M; Antonini F; Geissler A; Albanèse J; Martin C
Br J Anaesth; 2008 Apr; 100(4):504-8. PubMed ID: 18256055
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.
Cittanova ML; Leblanc I; Legendre C; Mouquet C; Riou B; Coriat P
Lancet; 1996 Dec; 348(9042):1620-2. PubMed ID: 8961992
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyethylstarch and renal function in kidney transplant recipients.
Holzheimer R
Lancet; 1997 Mar; 349(9055):883-4; author reply 884. PubMed ID: 9121292
[No Abstract] [Full Text] [Related]
5. Hydroxyethylstarch and renal function in kidney transplant recipients.
Coronel B; Mercatello A; Martin X; Lefrancois N
Lancet; 1997 Mar; 349(9055):884; author reply 884. PubMed ID: 9121293
[No Abstract] [Full Text] [Related]
6. [Hydroxyethylstarch and osmotic nephrosis].
Legendre C; Atinault A
Ann Fr Anesth Reanim; 1994; 13(5):766-7. PubMed ID: 7537479
[No Abstract] [Full Text] [Related]
7. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation.
Legendre C; Thervet E; Page B; Percheron A; Noël LH; Kreis H
Lancet; 1993 Jul; 342(8865):248-9. PubMed ID: 7686994
[No Abstract] [Full Text] [Related]
8. Update of our experience in long-term renal function of kidneys transplanted from non-heart-beating cadaver donors.
Castelao AM; Griñó JM; González C; Franco E; GilVernet S; Andrés E; Serón D; Torras J; Moreso F; Alsina J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1513-5. PubMed ID: 8442170
[No Abstract] [Full Text] [Related]
9. Outcomes of Kidney Transplantation from Circulatory Death Donors With Increased Terminal Creatinine Levels in Serum.
Tomita Y; Tojimbara T; Iwadoh K; Nakajima I; Fuchinoue S
Transplantation; 2016 Jul; 100(7):1532-40. PubMed ID: 26479288
[TBL] [Abstract][Full Text] [Related]
10. Long-term renal function of kidneys transplanted from non-heart-beating cadaver donors.
Castelao AM; Griñó JM; González C; GilVernet S; Andrés E; Serón D; Torras J; Galcerán JM; Bover J; Serrallach N
Transplant Proc; 1991 Oct; 23(5):2584-6. PubMed ID: 1926491
[No Abstract] [Full Text] [Related]
11. Outcome of a solitary kidney transplant into adult recipients from pediatric donors after controlled circulatory death.
Yuan Q; Zhang L; Wang L; Zeng L; Zhou M; Zhu Y; Li J; Chen Z
Exp Clin Transplant; 2011 Jun; 9(3):165-9. PubMed ID: 21649563
[TBL] [Abstract][Full Text] [Related]
12. Variables during care of adult donors that can influence outcomes of kidney transplantation.
Powner DJ
Prog Transplant; 2005 Sep; 15(3):219-24; quiz 225. PubMed ID: 16252627
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors.
Cittanova ML; Mavré J; Riou B; Coriat P
Intensive Care Med; 2001 Nov; 27(11):1830. PubMed ID: 11810131
[No Abstract] [Full Text] [Related]
14. Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function.
Mai ML; Mai WK; Taner CB; Prendergast MB; Wadei HM; Gonwa TA
Transplant Proc; 2013 May; 45(4):1528-30. PubMed ID: 23726612
[TBL] [Abstract][Full Text] [Related]
15. Effect of last donor creatininemia > 200 mumol/L on kidney graft function.
Alexandre L; Eschwege P; Decaris J; Joseph L; Charpentier B; Benoit G
Transplant Proc; 1996 Feb; 28(1):188. PubMed ID: 8644171
[No Abstract] [Full Text] [Related]
16. Five-year follow-up of 250 recipients of cadaveric kidney allografts from donors older than 55 years of age.
Lloveras J; Arias M; Andres A; Puig JM; Escallada R; Morales JM; Mir M; Cotorruelo JG; de Francisco AL; Masramon J
Transplant Proc; 1995 Feb; 27(1):981-3. PubMed ID: 7879254
[No Abstract] [Full Text] [Related]
17. Deceased donor management and demographic factors related to kidney allograft rejection and graft survival.
Slakey LM; Slakey CM; Slakey DP
Transplant Proc; 2010 Jun; 42(5):1513-8. PubMed ID: 20620465
[TBL] [Abstract][Full Text] [Related]
18. Risk factors among donor characteristics which affect graft outcome in paired kidney transplantation.
Tian YF; Liao CH; Chen MJ
Transplant Proc; 2008 Sep; 40(7):2281-4. PubMed ID: 18790212
[TBL] [Abstract][Full Text] [Related]
19. Administration of desmopressin in brain-dead donors and renal function in kidney recipients.
Guesde R; Barrou B; Leblanc I; Ourahma S; Goarin JP; Coriat P; Riou B
Lancet; 1998 Oct; 352(9135):1178-81. PubMed ID: 9777834
[TBL] [Abstract][Full Text] [Related]
20. Transplantation with kidneys retrieved from deceased donors with acute renal failure.
Klein R; Galante NZ; de Sandes-Freitas TV; de Franco MF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2013 Feb; 95(4):611-6. PubMed ID: 23274968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
